HKSE - Delayed Quote HKD

KAISA HEALTH (0876.HK)

Compare
0.024
+0.002
+(9.09%)
At close: 3:58:18 PM GMT+8
Loading Chart for 0876.HK
DELL
  • Previous Close 0.022
  • Open 0.023
  • Bid 0.023 x --
  • Ask 0.024 x --
  • Day's Range 0.023 - 0.024
  • 52 Week Range 0.015 - 0.050
  • Volume 690,000
  • Avg. Volume 1,112,270
  • Market Cap (intraday) 121.011M
  • Beta (5Y Monthly) 0.51
  • PE Ratio (TTM) --
  • EPS (TTM) -0.010
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date May 22, 2014
  • 1y Target Est --

Kaisa Health Group Holdings Limited, an investment holding company, engages in health care and dental business in the People's Republic of China and internationally. The company produces and sells dental prosthetics, including crowns and bridges, removable full and partial dentures, implants, and full-cast restorations, as well as provides sport rehabilitation and health leisure services. It is also involved in the investment holding of loan receivable, as well as trading and provision of medical technology development, medical consultation, and other medical services. The company was formerly known as Mega Medical Technology Limited and changed its name to Kaisa Health Group Holdings Limited in January 2018. Kaisa Health Group Holdings Limited was founded in 1971 and is headquartered in Central, Hong Kong.

www.kaisahealth.com

890

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 0876.HK

View More

Performance Overview: 0876.HK

Trailing total returns as of 1/13/2025, which may include dividends or other distributions. Benchmark is

.

YTD Return

0876.HK
4.00%
HANG SENG INDEX
5.82%

1-Year Return

0876.HK
29.41%
HANG SENG INDEX
16.19%

3-Year Return

0876.HK
72.41%
HANG SENG INDEX
22.65%

5-Year Return

0876.HK
90.59%
HANG SENG INDEX
34.09%

Compare To: 0876.HK

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 0876.HK

View More

Valuation Measures

As of 1/10/2025
  • Market Cap

    110.93M

  • Enterprise Value

    -22.18M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.61

  • Price/Book (mrq)

    0.24

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -31.24%

  • Return on Assets (ttm)

    -4.49%

  • Return on Equity (ttm)

    -11.88%

  • Revenue (ttm)

    181.81M

  • Net Income Avi to Common (ttm)

    -56.8M

  • Diluted EPS (ttm)

    -0.010

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    147.22M

  • Total Debt/Equity (mrq)

    3.09%

  • Levered Free Cash Flow (ttm)

    -25.19M

Research Analysis: 0876.HK

View More

People Also Watch